Log in to your Inderes Free account to see all free content on this page.
Diamyd Medical
1.33 SEK
-1.63 %
Less than 1K followers
DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Diamyd Medical
| 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | Q2/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | |
| EBITDA | -135.6 | -41.4 | -44.1 | -46.5 | -44.8 | -176.7 | -47.1 | -63.2 |
| EBIT | -146.6 | -42.9 | -45.7 | -48.1 | -46.5 | -183.2 | -48.8 | -65.0 |
| EBIT-% | -112,746.2 % | -143,066.7 % | -50,766.7 % | -258,388.9 % | -140,953.8 % | -20,014.8 % | -65,680.8 % | |
| Profit before taxes | -151.9 | -36.2 | -44.9 | -43.9 | -44.9 | -169.8 | -48.8 | -62.9 |
| Net income | -151.9 | -36.2 | -44.9 | -43.9 | -44.9 | -169.8 | -48.8 | -62.9 |
Login required
This content is only available for logged in users